#Zepatier has been approved to treat #HCV genotypes 1 and 4 in all 28 EU countries as well as Iceland, Liechtenstein and Norway!
#Zepatier has been approved to treat #HCV genotypes 1 and 4 in all 28 EU countries as well as Iceland, Liechtenstein and Norway!